Market Indices
Sector Heatmap
ORKA — Oruka Therapeutics, Inc. Common Stock
NasdaqOruka Therapeutics, Inc. Common Stock
- O
- 79.01
- H
- 81.40
- L
- 78.52
- V
- 809.88K
ORKA — Latest News & Headlines
13 StoriesORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data - Yahoo Finance
ORKA Stock Down 5% Despite Positive Week 28 Psoriasis Efficacy Data Yahoo Finance
25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). - Stock Titan
25,000 shares from a stock-option exercise are proposed for sale at Oruka Therapeutics (NASDAQ: ORKA). Stock Titan
How Investors Are Reacting To Oruka Therapeutics (ORKA) Positive Psoriasis Trial Results - Simply Wall Street
How Investors Are Reacting To Oruka Therapeutics (ORKA) Positive Psoriasis Trial Results Simply Wall Street
Understanding Momentum Shifts in (ORKA) - Stock Traders Daily
Understanding Momentum Shifts in (ORKA) Stock Traders Daily
Oruka Therapeutics stock price target maintained at $120 by H.C. Wainwright - Investing.com
Oruka Therapeutics stock price target maintained at $120 by H.C. Wainwright Investing.com
Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares - GuruFocus
Oruka Therapeutics (ORKA) CEO Lawrence Klein Sells 25,000 Shares GuruFocus
RDW vs. PL: Which Satellite Stock Has the Stronger Investment Case? - Zacks Investment Research
RDW vs. PL: Which Satellite Stock Has the Stronger Investment Case? Zacks Investment Research
Oruka Therapeutics: Review Of 28-Week Results Of ORKA-001, Q4 Data Previews (NASDAQ:ORKA) - Seeking Alpha
Oruka Therapeutics: Review Of 28-Week Results Of ORKA-001, Q4 Data Previews (NASDAQ:ORKA) Seeking Alpha
Oruka Therapeutics (ORKA) Just Gave Investors A Fresh Question - Simply Wall Street
Oruka Therapeutics (ORKA) Just Gave Investors A Fresh Question Simply Wall Street
Oruka Therapeutics CEO Klein sells $2.09m in stock - Investing.com
Oruka Therapeutics CEO Klein sells $2.09m in stock Investing.com
Piper Sandler reiterates Oruka Therapeutics stock rating on pipeline catalysts - Investing.com UK
Piper Sandler reiterates Oruka Therapeutics stock rating on pipeline catalysts Investing.com UK
Oruka Therapeutics Stock Stumbles After Hot Data Fade - TipRanks
Oruka Therapeutics Stock Stumbles After Hot Data Fade TipRanks
Oruka Therapeutics Tumbles As Biotech Rally Unravels - TipRanks
Oruka Therapeutics Tumbles As Biotech Rally Unravels TipRanks